Test Details
Methodology
See individual test components.
Result Turnaround Time
3 - 5 days
Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.
Use
Assessment of liver status following a diagnosis of HCV. Baseline determination of liver status before initiating HCV therapy. Posttreatment assessment of liver status six months after completion of therapy. Noninvasive assessment of liver status in patients who are at increased risk of complications from a liver biopsy.
Special Instructions
The patient's age and gender must be included on the test request form.
Limitations
This test was developed and its performance characteristics determined by Labcorp. It has not been cleared or approved by the Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary.
References
Specimen Requirements
Specimen
Serum
Volume
3.5 mL
Minimum Volume
2 mL
Container
Red-top tube or gel-barrier tube
Collection Instructions
Separate serum from cells within two hours of collection, and transfer serum to a transfer tube.
Stability Requirements
Temperature | Period |
---|---|
Room temperature | 72 hours (stability provided by manufacturer or literature reference) |
Refrigerated | 72 hours (stability provided by manufacturer or literature reference) |
Frozen | 7 days (stability provided by manufacturer or literature reference) |
Freeze/thaw cycles | Stable x1 (stability provided by manufacturer or literature reference) |
Reference Range
See tables.
Fibrosis Stage (FibroTest) | Range |
---|---|
F0−No fibrosis | 0.00−0.21 |
F0−F1 | >0.21−0.27 |
F1−Portal fibrosis | >0.27−0.31 |
F1−F2 | >0.31−0.48 |
F2−Bridging fibrosis with few septa | >0.48−0.58 |
F3−Bridging fibrosis with many septa | >0.58−0.72 |
F3−F4 | >0.72−0.74 |
F4−Cirrhosis | >0.74−1.00 |
Activity Stage (ActiTest) | Range |
---|---|
A0−No activity | 0.00−0.17 |
A0−A1 | >0.17−0.29 |
A1−Minimal activity | >0.29−0.36 |
A1−A2 | >0.36−0.52 |
A2−Moderate activity | >0.52−0.60 |
A2−A3 | >0.60−0.63 |
A3−Severe activity | >0.63−1.00 |
Storage Instructions
Specimen can be stored refrigerated at 2°C to 8°C for 72 hours and frozen at -70°C for seven days. Frozen samples are stable for one freeze/thaw cycle.
Patient Preparation
Patient should be fasting for at least eight hours.
Causes for Rejection
Gross hemolysis; gross lipemia; improper labeling; nonfasting specimen; patient younger than 14 years of age
LOINC® Map
Order Code | Order Code Name | Order Loinc | Result Code | Result Code Name | UofM | Result LOINC |
---|---|---|---|---|---|---|
550123 | HCV FibroSure | 48796-7 | 550102 | Fibrosis Score | 48795-9 | |
550123 | HCV FibroSure | 48796-7 | 550132 | Fibrosis Stage | 48794-2 | |
550123 | HCV FibroSure | 48796-7 | 550103 | Necroinflammat Activity Score | 48792-6 | |
550123 | HCV FibroSure | 48796-7 | 550133 | Necroinflammat Activity Grade | 48793-4 | |
550123 | HCV FibroSure | 48796-7 | 550398 | Methodology: | 62364-5 | |
550123 | HCV FibroSure | 48796-7 | 122137 | Alpha 2-Macroglobulins, Qn | mg/dL | 1835-8 |
550123 | HCV FibroSure | 48796-7 | 001629 | Haptoglobin | mg/dL | 4542-7 |
550123 | HCV FibroSure | 48796-7 | 016874 | Apolipoprotein A-1 | mg/dL | 1869-7 |
550123 | HCV FibroSure | 48796-7 | 001100 | Bilirubin, Total | mg/dL | 1975-2 |
550123 | HCV FibroSure | 48796-7 | 001960 | GGT | IU/L | 2324-2 |
550123 | HCV FibroSure | 48796-7 | 001547 | ALT (SGPT) P5P | IU/L | 1743-4 |
550123 | HCV FibroSure | 48796-7 | 550106 | Interpretations: | N/A | |
550123 | HCV FibroSure | 48796-7 | 550107 | Fibrosis Scoring: | N/A | |
550123 | HCV FibroSure | 48796-7 | 550121 | Necroinflamm Activity Scoring: | N/A | |
550123 | HCV FibroSure | 48796-7 | 550105 | Limitations: | 8251-1 | |
550123 | HCV FibroSure | 48796-7 | 550127 | Comment: | 77202-0 | |
550123 | HCV FibroSure | 48796-7 | 123094 | Comment: | 77202-0 | |
Order Code | 550123 | |||||
Order Code Name | HCV FibroSure | |||||
Order Loinc | 48796-7 | |||||
Result Code | 550102 | |||||
Result Code Name | Fibrosis Score | |||||
UofM | ||||||
Result LOINC | 48795-9 | |||||
Order Code | 550123 | |||||
Order Code Name | HCV FibroSure | |||||
Order Loinc | 48796-7 | |||||
Result Code | 550132 | |||||
Result Code Name | Fibrosis Stage | |||||
UofM | ||||||
Result LOINC | 48794-2 | |||||
Order Code | 550123 | |||||
Order Code Name | HCV FibroSure | |||||
Order Loinc | 48796-7 | |||||
Result Code | 550103 | |||||
Result Code Name | Necroinflammat Activity Score | |||||
UofM | ||||||
Result LOINC | 48792-6 | |||||
Order Code | 550123 | |||||
Order Code Name | HCV FibroSure | |||||
Order Loinc | 48796-7 | |||||
Result Code | 550133 | |||||
Result Code Name | Necroinflammat Activity Grade | |||||
UofM | ||||||
Result LOINC | 48793-4 | |||||
Order Code | 550123 | |||||
Order Code Name | HCV FibroSure | |||||
Order Loinc | 48796-7 | |||||
Result Code | 550398 | |||||
Result Code Name | Methodology: | |||||
UofM | ||||||
Result LOINC | 62364-5 | |||||
Order Code | 550123 | |||||
Order Code Name | HCV FibroSure | |||||
Order Loinc | 48796-7 | |||||
Result Code | 122137 | |||||
Result Code Name | Alpha 2-Macroglobulins, Qn | |||||
UofM | mg/dL | |||||
Result LOINC | 1835-8 | |||||
Order Code | 550123 | |||||
Order Code Name | HCV FibroSure | |||||
Order Loinc | 48796-7 | |||||
Result Code | 001629 | |||||
Result Code Name | Haptoglobin | |||||
UofM | mg/dL | |||||
Result LOINC | 4542-7 | |||||
Order Code | 550123 | |||||
Order Code Name | HCV FibroSure | |||||
Order Loinc | 48796-7 | |||||
Result Code | 016874 | |||||
Result Code Name | Apolipoprotein A-1 | |||||
UofM | mg/dL | |||||
Result LOINC | 1869-7 | |||||
Order Code | 550123 | |||||
Order Code Name | HCV FibroSure | |||||
Order Loinc | 48796-7 | |||||
Result Code | 001100 | |||||
Result Code Name | Bilirubin, Total | |||||
UofM | mg/dL | |||||
Result LOINC | 1975-2 | |||||
Order Code | 550123 | |||||
Order Code Name | HCV FibroSure | |||||
Order Loinc | 48796-7 | |||||
Result Code | 001960 | |||||
Result Code Name | GGT | |||||
UofM | IU/L | |||||
Result LOINC | 2324-2 | |||||
Order Code | 550123 | |||||
Order Code Name | HCV FibroSure | |||||
Order Loinc | 48796-7 | |||||
Result Code | 001547 | |||||
Result Code Name | ALT (SGPT) P5P | |||||
UofM | IU/L | |||||
Result LOINC | 1743-4 | |||||
Order Code | 550123 | |||||
Order Code Name | HCV FibroSure | |||||
Order Loinc | 48796-7 | |||||
Result Code | 550106 | |||||
Result Code Name | Interpretations: | |||||
UofM | ||||||
Result LOINC | N/A | |||||
Order Code | 550123 | |||||
Order Code Name | HCV FibroSure | |||||
Order Loinc | 48796-7 | |||||
Result Code | 550107 | |||||
Result Code Name | Fibrosis Scoring: | |||||
UofM | ||||||
Result LOINC | N/A | |||||
Order Code | 550123 | |||||
Order Code Name | HCV FibroSure | |||||
Order Loinc | 48796-7 | |||||
Result Code | 550121 | |||||
Result Code Name | Necroinflamm Activity Scoring: | |||||
UofM | ||||||
Result LOINC | N/A | |||||
Order Code | 550123 | |||||
Order Code Name | HCV FibroSure | |||||
Order Loinc | 48796-7 | |||||
Result Code | 550105 | |||||
Result Code Name | Limitations: | |||||
UofM | ||||||
Result LOINC | 8251-1 | |||||
Order Code | 550123 | |||||
Order Code Name | HCV FibroSure | |||||
Order Loinc | 48796-7 | |||||
Result Code | 550127 | |||||
Result Code Name | Comment: | |||||
UofM | ||||||
Result LOINC | 77202-0 | |||||
Order Code | 550123 | |||||
Order Code Name | HCV FibroSure | |||||
Order Loinc | 48796-7 | |||||
Result Code | 123094 | |||||
Result Code Name | Comment: | |||||
UofM | ||||||
Result LOINC | 77202-0 |